News

Lawrence Livermore National Laboratory (LLNL) is expanding its deployment of Anthropic's Claude for Enterprise to its entire ...
Breakthroughs from two rival experiments, Germany’s Wendelstein 7-X and the Joint European Torus, suggest the elusive dream ...
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
With more than a decade of productive partnership in advancing high-power laser technology, Lawrence Livermore National ...
A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...
The US' Lawrence Livermore National Laboratory (LLNL) has partnered with Amazon Web Services (AWS) for an AI-driven troubleshooting and reliability system at LLNL's National Ignition Facility (NIF).
“We are looking forward to expanding our existing collaborations with ELI on areas such as ultrabright high-repetition-rate ...
A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...
A paper on fusion neutron sources by a team from the United States of America’s Lawrence Livermore National Laboratory and the University of Rochester has won the IAEA’s annual Nuclear Fusion prize.
A new algorithm helps topology optimizers skip unnecessary iterations, making optimization and design faster, more stable and ...
But now, researchers at the Lawrence Livermore National Laboratory believe they have a cheaper and potentially more powerful way to monitor seismic activity. "Yeah.